Kazumasa Oya
Tsukuba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Eribulin promotes dendritic cell activation and migration in the murine tumor microenvironment.
Journal: Journal of dermatological science
Published: December 10, 2025
Clinical and histopathological features of alopecia associated with enfortumab vedotin treatment.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 14, 2025
A Case of Recurrent Atypical Lipomatous Tumor.
Journal: The American Journal of dermatopathology
Published: October 16, 2024
Late-onset comedonal Darier disease with a novel frameshift mutation in ATP2A2.
Journal: European journal of dermatology : EJD
Published: March 11, 2024
Tinea incognito caused by Microsporum canis mimicking erythema gyratum repens: a diagnostic challenge.
Journal: European journal of dermatology : EJD
Published: February 01, 2024
COVID-19-associated pemphigus foliaceus exacerbated by toll-like receptor 7 agonist.
Journal: The Journal of dermatology
Published: January 09, 2024
Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.
Journal: The Journal of dermatology
Published: December 01, 2023
Milia-like appearance of vulvar syringoma.
Journal: The Journal of dermatology
Published: November 08, 2023
Metastatic melanoma of the oral cavity showing prompt regression with the use of BRAF/MEK inhibitors.
Journal: The Journal of dermatology
Published: September 25, 2023
Erythroderma with brentuximab vedotin in a patient with mycosis fungoides.
Journal: European journal of dermatology : EJD
Published: July 11, 2023
Amicrobial pustulosis of the folds concurrent with graft-versus-host disease.
Journal: The Journal of dermatology
Published: June 25, 2023
Last Updated: 09/26/2026